Position in HIMS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$43,971,340
-$112,469,412 QoQ
Shares Held
2,118,080
-56.0% QoQ
Ownership
0.908%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in HIMS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,971,340 | 2,118,080 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $156,440,752 | 4,818,009 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $515,973,445 | 9,096,852 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $342,442,182 | 6,869,452 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $207,569,601 | 7,024,352 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $168,078,855 | 6,951,152 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $99,262,617 | 5,388,850 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $121,935,647 | 6,039,408 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $43,846,621 | 2,834,300 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,786,539 | 650,173 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,394,634 | 1,334,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,054,560 | 1,282,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $15,582,336 | 1,570,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,670,767 | 1,508,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,452,584 | 1,514,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,874,723 | 1,959,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,968,258 | 1,682,600 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,932,998 | 1,058,473 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,908,676 | 1,579,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $190,575 | 17,500 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||